title: Parvovirus B19-associated interstitial lung disease, hepatitis, and myositis.
authors.affiliation: Combined Program in Gastroenterology and Nutrition, Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
authors.forename: A
authors.initials: A
authors.lastname: Bousvaros
authors.forename: R
authors.initials: R
authors.lastname: Sundel
authors.forename: G M
authors.initials: GM
authors.lastname: Thorne
authors.forename: K
authors.initials: K
authors.lastname: McIntosh
authors.forename: M
authors.initials: M
authors.lastname: Cohen
authors.forename: D D
authors.initials: DD
authors.lastname: Erdman
authors.forename: A
authors.initials: A
authors.lastname: Perez-Atayde
authors.forename: T H
authors.initials: TH
authors.lastname: Finkel
authors.forename: A A
authors.initials: AA
authors.lastname: Colin
mesh_terms: D002648:Child; D018549:Cryptogenic Organizing Pneumonia / Q000175:diagnosis / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D006525:Hepatitis, Viral, Human / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D017563:Lung Diseases, Interstitial / Q000175:diagnosis* / Q000188:drug therapy; D009220:Myositis / Q000175:diagnosis* / Q000188:drug therapy; D010322:Parvoviridae Infections / Q000175:diagnosis* / Q000188:drug therapy; D016732:Parvovirus B19, Human
chemical_list: D007166:Immunosuppressive Agents; D003520:Cyclophosphamide